Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Antigens”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Testing effectiveness (Phase 2)WithdrawnNCT01561482
What this trial is testing

Study of Metformin With Simvastatin for Men With Prostate Carcinoma

Who this might be right for
Prostate Carcinoma
Nicholas Mitsiades
Testing effectiveness (Phase 2)Study completedNCT00286806
What this trial is testing

Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Ascenta Therapeutics 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03976843
What this trial is testing

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 175
Large-scale testing (Phase 3)Study completedNCT00136487
What this trial is testing

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 85
Not applicableActive Not RecruitingNCT05228197
What this trial is testing

Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.

Who this might be right for
Prostatic Neoplasms
Imperial College London 750
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Early research (Phase 1)UnknownNCT00005992
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT07813637
What this trial is testing

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC

Who this might be right for
Prostate CancerCastration-Resistant Prostate Cancer (CRPC)Metastatic Prostate Cancer+1 more
Janux Therapeutics 110
Testing effectiveness (Phase 2)Looking for participantsNCT04175431
What this trial is testing

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Who this might be right for
Prostate Adenocarcinoma
University of Washington 100
Testing effectiveness (Phase 2)UnknownNCT03579654
What this trial is testing

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 120
Early research (Phase 1)Study completedNCT01414283
What this trial is testing

Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 52
Large-scale testing (Phase 3)Ended earlyNCT00840294
What this trial is testing

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

Who this might be right for
Elevated Prostate Specific Antigen
University of Chicago 85
Not applicableStudy completedNCT01118741
What this trial is testing

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT05114746
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT01162135
What this trial is testing

Digoxin for Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 16
Testing effectiveness (Phase 2)Looking for participantsNCT05155046
What this trial is testing

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

Who this might be right for
Localized Prostate Cancer
National Cancer Institute (NCI) 130
Large-scale testing (Phase 3)UnknownNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Not applicableStudy completedNCT02155998
What this trial is testing

Non-Interventional Study PREVENT

Who this might be right for
Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients
AstraZeneca 200
Large-scale testing (Phase 3)Looking for participantsNCT05939414
What this trial is testing

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Who this might be right for
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals 450
Next Page